United States · FDA National Drug Code directory
Rolvedon
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82497-132_ef8eef01-b278-484e-b4d4-85905e756674
- Product NDC
- 82497-132
- Form
- INJECTION, SOLUTION
- Composition / generic term
- eflapegrastim-xnst
- Labeler
- Assertio Specialty Pharmaceuticals, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20251211
- Source listing expiry
- 20271231
Source-listed ingredients
- EFLAPEGRASTIM — 13.2 mg/.6mL
These values do not establish equivalence or a dose recommendation.
Packages
- .6 mL in 1 SYRINGE, GLASS (82497-132-01) · 82497-132-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →